LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 86.79 | 17.25 | 900 | 6008 | 0.1498 | 0.5973 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 86.79 | 17.25 | 59 | 6008 | 0.0098 | 0.1568 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 86.79 | 17.25 | 1281 | 6008 | 0.2132 | 0.6655 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 88.76 | 17.25 | 861 | 6047 | 0.1424 | 0.5881 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 88.76 | 17.25 | 882 | 6047 | 0.1458 | 0.5927 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 88.76 | 17.25 | 55 | 6047 | 0.0091 | 0.1470 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 88.76 | 17.25 | 1131 | 6047 | 0.1870 | 0.6402 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 90.74 | 17.25 | 857 | 6109 | 0.1403 | 0.5860 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 90.74 | 17.25 | 879 | 6109 | 0.1439 | 0.5907 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 90.74 | 17.25 | 53 | 6109 | 0.0087 | 0.1417 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 90.74 | 17.25 | 1107 | 6109 | 0.1812 | 0.6347 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 92.71 | 17.25 | 856 | 6184 | 0.1384 | 0.5843 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 92.71 | 17.25 | 881 | 6184 | 0.1425 | 0.5896 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 92.71 | 17.25 | 56 | 6184 | 0.0091 | 0.1488 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 92.71 | 17.25 | 1126 | 6184 | 0.1821 | 0.6363 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 94.68 | 17.25 | 866 | 6239 | 0.1388 | 0.5853 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 94.68 | 17.25 | 898 | 6239 | 0.1439 | 0.5921 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 94.68 | 17.25 | 60 | 6239 | 0.0096 | 0.1580 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 94.68 | 17.25 | 1084 | 6239 | 0.1737 | 0.6278 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 3.06 | 17.25 | 607 | 143 | 4.2384 | 2.2095 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 3.06 | 17.25 | 737 | 143 | 5.1461 | 2.4202 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 5.03 | 17.25 | 891 | 273 | 3.2595 | 1.6901 | MN20160310_N02 | I09 |